Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-08-02
1986-01-28
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
424 85, 260112R, 260112B, A61K 3940, A61K 39395, C07G 700
Patent
active
045670412
ABSTRACT:
A novel mutant strain of Listeria monocytogenes has been discovered which functions as a killed strain not only as an antigen resulting in the production of relatively large titers of IgM antibodies in host animals but also as an immunopotentiating agent when conjugated to a sensitising antigen, for example, living tumor cells and herpes simplex virus. The high molecular weight IgM antibodies are readily separated from serum and recovered without loss of appreciable activity. The IgM antibodies can be divided into five subunits of IgG antibodies, of lesser molecular weight, having the same specificity as the IgM immunoglobulins. When the sensitizing antigens conjugated with the Listeria monocytogenes strain of this invention are tumor cells, the conjugate acts as an immunotherapeutic agent effective in cancer immunotherapy.
REFERENCES:
patent: 3766162 (1973-10-01), Spector et al.
patent: 3809782 (1974-05-01), Spector
Gatewood Herbert L.
Hazel Blondel
LandOfFree
Mutant strain of Listeria monocytogenes and its use in productio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant strain of Listeria monocytogenes and its use in productio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant strain of Listeria monocytogenes and its use in productio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1305635